82172716/National Natural Science Foundation of China[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2022	1
2024	2
2025	0

Page 1

Efficacy and safety of perioperative immunotherapy combinations for resectable non-small cell lung cancer: a systematic review and network meta-analysis.

Han Y, Xiao X, Qin T, Yao S, Liu X, Feng Y, Li Z, Li Y, Xia S. Han Y, et al. Cancer Immunol Immunother. 2024 Oct 9;73(12):262. doi: 10.1007/s00262-024-03844-w. Cancer Immunol Immunother. 2024. PMID: 39382658 Free PMC article. Review.

Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway.

Li P, Li L, Li Z, Wang S, Li R, Zhao W, Feng Y, Huang S, Li L, Qiu H, Xia S. Li P, et al. Cancer Cell Int. 2022 Jan 6;22(1):7. doi: 10.1186/s12935-021-02427-4. Cancer Cell Int. 2022. PMID: 34991599 Free PMC article.

Construction of a Novel Damage-Associated Molecular-Pattern-Related Signature to Assess Lung Adenocarcinoma's Prognosis and Immune Landscape.

Liu X, Yao S, Feng Y, Li P, Li Y, Xia S. Liu X, et al. Biomolecules. 2024 Jan 15;14(1):108. doi: 10.3390/biom14010108. Biomolecules. 2024. PMID: 38254708 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year